Exforge Hct Tablet, Film Coated
Product Images NDC 0078-0560

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Exforge Hct (NDC 0078-0560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Structural Formula (Exforge Hct 01)

Chemical structure diagram showing two distinct molecules. The left molecule includes a chlorine atom, ester groups, and an amine side chain, while the right molecule is a benzene ring with a sulfonic acid (SO3H) group. This likely represents a chemical structure related to the active ingredients in the product Exforge HCT.*

FDA Label Image

Valsartan Structural Formula (Exforge Hct 02)

Chemical structure of amlodipine, one of the active ingredients in Exforge HCT tablets. The diagram shows the molecular arrangement including rings, functional groups, and bonds characteristic of amlodipine.*

FDA Label Image

Hydrochlorothiazide Structural Formula (Exforge Hct 03)

Chemical structure of hydrochlorothiazide, an active ingredient in Exforge HCT. The diagram shows the molecular arrangement including sulfur, chlorine, nitrogen, and other atoms characteristic of hydrochlorothiazide.*

FDA Label Image

Figure 1: Reduction In Mean Blood Pressure At Endpoint (Exforge Hct 04)

A bar chart comparing diastolic and systolic blood pressure changes across four treatment groups: HCTZ/Aml 25/10, Val/HCTZ 320/25, Aml/Val 10/320, and Aml/Val/HCTZ 10/320/25. Values are presented as negative changes in blood pressure, showing differences among the treatments.*

FDA Label Image

Figure 2: Mean Sitting Diastolic Blood Pressure By Treatment And Week (Exforge Hct 05)

A line graph depicting mean sitting diastolic blood pressure (DBP) in mmHg over 8 weeks. The graph compares four treatments of drug combinations involving amlodipine, valsartan, and hydrochlorothiazide with different dosages, showing trends in DBP reduction from baseline to week 8.*

FDA Label Image

Figure 3: Mean Sitting Systolic Blood Pressure By Treatment And Week (Exforge Hct 06)

A line graph showing mean sitting systolic blood pressure (SBP) in mmHg over 8 weeks for different treatments: Amlodipine/valsartan/hydrochlorothiazide (Aml/Val/HCTZ) 10/320/25 mg, Amlodipine/valsartan (Aml/Val) 10/320 mg, Valsartan/hydrochlorothiazide (Val/HCTZ) 320/25 mg, and hydrochlorothiazide/amlodipine (HCTZ/Aml) 25/10 mg. The graph illustrates a decline in mean SBP over the treatment period.*

FDA Label Image

Figure 4: Mean Ambulatory Diastolic Blood Pressure At Endpoint By Treatment And Hour (Exforge Hct 07)

A line graph depicting mean ambulatory diastolic blood pressure (DBP) over 24 hours after dosing. The chart compares four treatments: Amlodipine/Valsartan/Hydrochlorothiazide 10/320/25 mg, Valsartan/Hydrochlorothiazide 320/25 mg, Amlodipine/Valsartan 10/320 mg, and Hydrochlorothiazide/Amlodipine 25/10 mg. The x-axis shows hours after dosing from 0 to 24, and the y-axis shows mean DBP in mmHg.*

FDA Label Image

Figure 5: Mean Ambulatory Systolic Blood Pressure At Endpoint By Treatment And Hour (Exforge Hct 08)

A line graph showing mean ambulatory systolic blood pressure (SBP) over 24 hours post-dosing for different treatments of Exforge HCT combinations, including amlodipine, valsartan, and hydrochlorothiazide in various dosages. The x-axis represents hours after dosing, and the y-axis shows SBP in mmHg.*

FDA Label Image

Principal Display Panelpackage Label – 5 mg / 160 mg / 12.5 mgrx Only Ndc 0078-0559-15exforge Hct® (amlodipine, Valsartan, Hydrochlorothiazide)5 mg* / 160 mg / 12.5 mg*each Tablet Contains 6.9 mg Of Amlodipine Besylate30 Tablets (Exforge Hct 09)

Label for Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets containing amlodipine, valsartan, and hydrochlorothiazide. The package contains 30 tablets for oral use, labeled Rx only. Manufactured by Novartis Pharmaceuticals Corporation, the label includes dosage and storage instructions along with a barcode and NDC 0078-0559-15.*

FDA Label Image

Exforge Hct 10

Exforge HCT 5 mg/160 mg/25 mg film-coated tablets packaging label from Novartis Pharmaceuticals Corporation. The label displays the product name, active ingredients (amlodipine, valsartan, and hydrochlorothiazide), strength, and tablet count (30 tablets). It includes the NDC number 0078-0560-15 and dosage storage instructions on the right side.*

FDA Label Image

Exforge Hct 11

Exforge HCT amlodipine, valsartan, and hydrochlorothiazide tablets 10 mg / 160 mg / 12.5 mg, film-coated oral tablets, in a 30-tablet package. The label shows prescription use only and is manufactured by Novartis Pharmaceuticals Corporation. The label includes storage instructions and references to prescribing information.*

FDA Label Image

Exforge Hct 12

Label for Exforge HCT film-coated tablets containing amlodipine, valsartan, and hydrochlorothiazide 10 mg, 160 mg, and 25 mg respectively. The package holds 30 tablets and is marked Rx only. Labeler is Novartis Pharmaceuticals Corporation. Storage and dosing instructions are included on the label.*

FDA Label Image

Exforge Hct 13

Exforge HCT amlodipine, valsartan, and hydrochlorothiazide tablets, 10 mg/320 mg/25 mg strength, film-coated oral tablets. The label indicates a package containing 30 tablets, prescription use only. Manufactured by Novartis Pharmaceuticals Corporation. The label includes dosage guidance and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.